CORE Diagnostics, a provider of high-end diagnostics services, said on Friday that Eight Roads Ventures, US-based F-Prime Capital Partners and existing investor Artiman Ventures will invest $12 million in the company. Terms of the transaction were not disclosed.
The company will use the investment to introduce multiple new advanced tests for oncology as well as for other segments such as infectious diseases and gynaecology.
